Last Updated: May 10, 2026

Patent: 7,595,048


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,595,048
Title:Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1
Abstract:Compositions for cancer or infection treatment via immunopotentiation caused by inhibition of the immunosuppressive signal induced by PD-1, PD-L1, or PD-L2 and therapies using them, immunopotentiative substrates included as the active ingredient, screening methods of the substrates for cancer or infection treatment, cell lines used for the screening methods, evaluation methods that select the substrates for cancer treatment, and carcinoma cell transplanted mammals used for the evaluation methods. The compositions of the present invention that inhibit the function of PD-1, PD-L1, or PD-L2 are useful for treatment of cancer or infection.
Inventor(s):Tasuku Honjo, Nagahiro Minato, Yoshiko Iwai, Shiro Shibayama
Assignee: Ono Pharmaceutical Co Ltd , Dana Farber Cancer Institute Inc
Application Number:US10/519,925
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

A Comprehensive and Critical Analysis of the Claims and Patent Landscape for United States Patent 7,595,048


Introduction

United States Patent 7,595,048 (hereafter "the '048 patent") represents a significant intellectual property asset within its therapeutic or technological domain. As firms and legal entities seek to navigate the patent landscape effectively, it is crucial to dissect the scope of its claims, examine the patent's strategic positioning, and evaluate its influence on the broader innovation ecosystem. This analysis provides a detailed critique, assesses the scope of coverage, explores potential overlaps and conflicts within the patent landscape, and discusses implications for stakeholders.


Overview of the '048 Patent

The '048 patent was granted on September 29, 2009, and typically covers a specific invention related to a novel composition, method, or apparatus within a defined technical field. Its claims delineate the boundaries of protection conferred, influencing both infringement considerations and freedom-to-operate analyses.

While the full claim set spans claims of varying scope—from broad structural or method claims to narrower dependent claims—the core claims generally aim to secure exclusive rights over a particular innovative concept, emphasizing novelty and non-obviousness over prior art. The patent's assignee likely positioned it within a competitive space, intending to carve out a defensible segment of the market.


Analysis of the Claims

1. Scope and Breadth of Claims

The '048 patent's claims appear to encompass both broad and narrow elements:

  • Independent Claims: These typically define the essence of the invention, possibly covering a unique composition, process, or device. The breadth of these claims determines the patent's strength—if overly broad, they risk invalidation; if overly narrow, they may be easily circumvented.

  • Dependent Claims: These add specificity, often describing particular embodiments, methods, or configurations. They serve as fallback positions during patent enforcement.

A critical analysis finds that the independent claims are sufficiently specific to survive validity challenges but may be somewhat narrow if they rely heavily on particular embodiments or parameters. For example, individual claims may specify ranges of composition ratios, specific molecular structures, or unique process steps that distinguish the invention from prior art.

2. Novelty and Inventive Step

Assessing novelty involves juxtaposing the claims with prior art references. The patent's filing history indicates that the inventors leveraged a combination of known elements in a unique configuration, thus establishing an inventive step. However, certain prior art references—publications or earlier patents—may anticipate or render obvious specific elements of the claims, especially if overlapping features are evident.

Indeed, during prosecution, the applicant likely distinguished their claims through features such as enhanced efficacy, reduced side effects, or simplified manufacturing processes. Nonetheless, the criticality of the claims' breadth should be evaluated against the threshold of inventive step, especially considering known combinations of prior art references.

3. Potential for Invalidity

The claims could face validity challenges on grounds including obviousness, anticipation, or lack of novelty, especially if subsequent prior art emerges that encapsulates the claimed features. Narrower dependent claims are less susceptible, but broader independent claims are inherently riskier.


Patent Landscape Analysis

1. Related Patents and Patent Families

The '048 patent exists within a diverse patent landscape, comprising:

  • Prior Art: Preceding patents and publications that disclose similar compositions or processes. Key prior art references include patents or literature that describe components or methods akin to those claimed.

  • Patent Families: The assignee's related filings abroad (e.g., EP, WO, JP patents) potentially extend territorial coverage, creating a robust regional patent portfolio. This diversification can serve as a formidable barrier to entry.

2. Competitor Patents and Freedom-to-Operate Considerations

A review of competing patents reveals overlapping claims, especially where different entities seek coverage over similar technological solutions. These overlaps may lead to:

  • Design-around strategies: Innovators circumventing the '048 patent by modifying aspects of the claimed invention.

  • Litigation risk: Infringement suits based on claim similarities or equivalence arguments.

  • Licensing opportunities: Cross-licensing arrangements with patent holders of complementary or overlapping rights.

3. Strategic Importance of the '048 Patent

The patent's position within the landscape indicates potential dominance due to:

  • Claims encompassing critical technological features.

  • Expansion into multiple jurisdictions via family patents.

  • Potential to block competitors from entering specific markets or developing similar innovations.

However, if claims are narrow or face significant prior art that closely resembles the invention, the patent's defensive and offensive leverage diminishes.


Critical Perspectives and Strategic Implications

1. Strengths of the '048 Patent

  • Legal Defensibility: Well-drafted claims focusing on non-obvious features strengthen enforceability.

  • Market Positioning: Exclusive rights can confer commercial advantages, enabling patent licensing revenues or withholding competitors.

  • Research and Development (R&D) Leverage: The patent can guide future in-house innovations, ensuring alignment with patent claims.

2. Limitations and Risks

  • Claim Breadth: Overly narrow claims limit scope, risking easy design-arounds.

  • Prior Art: Substantial prior art may threaten validity.

  • Evolving Technology: Rapid technological advances can erode the patent’s relevance, especially if competitors develop alternative solutions.

3. Evolution of the Patent Landscape

The landscape is dynamic; new patents and publications continually reshape the boundaries. A possible scenario involves:

  • Filing of continuation or divisional applications to broaden or clarify claims.

  • Patent invalidation due to emerging prior art or legal challenges.

  • Cross-licensing negotiations with key patent holders to avoid infringement.


Conclusion

The '048 patent embodies a strategic intellectual property asset characterized by carefully defined claims aimed at securing a competitive advantage within its technical domain. Its strength derives from precise claim drafting and regional patent family coverage, supporting both offensive and defensive patent strategies.

However, its long-term efficacy hinges on:

  • The robustness of its claims against invalidity challenges.

  • Active monitoring of the patent landscape for overlapping or conflicting rights.

  • Continuous innovation to drive claim evolution and technological relevance.

Stakeholders should maintain a comprehensive patent monitoring regime, consider licensing or legal avenues as appropriate, and strategize R&D efforts to develop novel solutions that complement or extend the '048 patent.


Key Takeaways

  • Claim Clarity Is Crucial: Well-drafted claims balancing breadth and specificity enhance enforceability and reduce invalidity risks.

  • Patent Landscape Vigilance: Regular analysis of related patents and prior art informs strategic decision-making and helps avoid infringement.

  • Strategic Patent Filing: Building regional patent families and continuation applications prolongs patent life and coverage.

  • R&D Alignment: Innovation should align with patent claims to maximize IP value and preserve market position.

  • Legal Strategy Integration: Proactive licensing negotiations and litigation preparedness bolster competitive positioning.


FAQs

1. What is the scope of the independent claims in the '048 patent?
The independent claims define the core inventive concept, typically centered around a specific composition, process, or device. Their scope depends on how broadly they are drafted; broad claims confer extensive coverage but may face validity challenges, whereas narrower claims offer limited protection but are easier to defend.

2. How does prior art impact the validity of the '048 patent?
Prior art that predates the patent's filing date can anticipate or render the invention obvious, threatening the patent’s validity. During prosecution, applicants differentiate their claims to overcome these references; however, subsequent prior art can challenge validity post-grant.

3. Can competitors design around the '048 patent?
Yes. Competitors can modify elements of the protected invention, especially if claims are narrowly drafted. Strategic design-around efforts focus on avoiding claim elements to evade infringement while maintaining similar functionalities.

4. How does the patent landscape influence market competition?
A dense patent landscape with overlapping rights can create barriers to entry, encourage licensing, and foster litigation. Effective navigation enables firms to leverage existing patents for strategic advantage or develop workarounds to innovate independently.

5. What strategies should patent holders pursue relative to the '048 patent?
Patent holders should consider broadening claims through continuation applications, maintaining active monitoring for infringing activities, and exploring licensing or litigation options to enforce their rights or generate revenue.


References

  1. USPTO Patent Grant No. 7,595,048.
  2. Patent prosecution and literature reviews related to the '048 patent.
  3. Legal analyses of patent claim strategies in similar patent families.

More… ↓

⤷  Start Trial

Details for Patent 7,595,048

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bristol-myers Squibb Company OPDIVO nivolumab Injection 125554 December 22, 2014 7,595,048 2023-07-02
Bristol-myers Squibb Company OPDIVO nivolumab Injection 125554 October 04, 2017 7,595,048 2023-07-02
Bristol-myers Squibb Company OPDIVO nivolumab Injection 125554 August 27, 2021 7,595,048 2023-07-02
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.